A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
To determine if treatment with paclitaxel plus AMG 706 is superior to paclitaxel plus AMG 706
placebo in subjects with HER2 negative locally recurrent or metastatic breast cancer. Also to
estimate differences between treatment with paclitaxel plus AMG 706 and paclitaxel plus
bevacizumab.